|
FY2026
12 months to Aug 29, 2026
|
FY2025
12 months to Aug 30, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 26, 2023
|
FY2022
12 months to Aug 27, 2022
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation | |||||
| Amortization | |||||
| Non-cash interest expense, net | |||||
| Amortization of debt issuance costs | |||||
| Last in, first-out ("LIFO") expense | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Deferred compensation expense | |||||
| Goodwill impairment (Note 6) | |||||
| Loss on note repurchase (Note 8) | |||||
| Asset impairment | |||||
| Restructuring and related costs | |||||
| Contingent consideration fair value adjustment | |||||
| Payments of earnout liability above acquisition-date fair value | |||||
| Other, net | |||||
| Change in operating assets and liabilities, net of assets and liabilities acquired | |||||
| Receivables, net | |||||
| Inventories, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Income taxes and unrecognized tax benefits | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property, plant, and equipment | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from the sale of property, plant, and equipment | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Borrowings on long-term debt | |||||
| Repayments on long-term debt | |||||
| Payments for convertible note bond hedge | |||||
| Proceeds from issuance of convertible note warrant | |||||
| Proceeds from partial unwind of convertible note bond hedge | |||||
| Payments for partial unwind of convertible note warrant | |||||
| Payments of cash dividends | |||||
| Payments for repurchases of common stock | |||||
| Payments of debt issuance costs | |||||
| Payments of earnout liability up to acquisition-date fair value | |||||
| Other, net | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosures | |||||
| Income taxes paid, net | |||||
| Interest paid | |||||
| Non-cash investing and financing activities | |||||
| Issuance of common stock for acquisition of business | |||||
| Issuance of common stock for settlement of earnout liability | |||||
| Capital expenditures in accounts payable | |||||
| Dividends declared not yet paid | |||||
| Increase in lease assets in exchange for lease liabilities: | |||||
| Operating leases | |||||
| Financing leases | |||||
Loading...